Supplements News and Research

RSS

Researchers confirm link between neonatal vitamin D deficiency and schizophrenia

Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported.

7 Dec 2018

Elevated hormone flags liver disease in mice with serious genomic disorder

Researchers have discovered that a hormone, fibroblast growth factor 21 (FGF21), is extremely elevated in mice with liver disease that mimics the same condition in patients with methylmalonic acidemia (MMA), a serious genomic disorder.

6 Dec 2018

Newborns with vitamin D deficiency have increased risk of schizophrenia later in life

Newborns with Vitamin D deficiency have an increased risk of schizophrenia later in life, researchers from Aarhus University and the University of Queensland report.

6 Dec 2018

Fish oil does not increase perioperative bleeding in surgery patients

A new study published in Circulation showed that fish oil -- which contains the omega-3s EPA and DHA -- did not increase perioperative bleeding in surgery patients. In fact, higher blood omega-3 levels were associated with lower risk of bleeding.

4 Dec 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

Johns Hopkins researchers report challenges in treating severe crisis pain of sickle cell disease

In a study tracking the severe crisis pain of sickle cell disease and its management in 73 adults over a period of a year, Johns Hopkins researchers found that even among those on high doses of daily at-home opioids, a persistent subset was more likely to seek emergency hospital care for crisis pain and was less likely to have the pain controlled by intensive treatment.

27 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

Certain dietary supplements can have beneficial effect on sperm quality, study suggests

Infertility affects 15% of the world population and is recognized by the World Health Organisation as a global health problem.

26 Nov 2018

NanoSphere develops new intraoral product that has potential to revolutionize cannabis therapies

NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.

26 Nov 2018

Supplements of key nutrients can help people to see better

Inside fruit and vegetables are pigments, known as carotenoids, which can boost health. Three of these – lutein, zeaxanthin and meso-zeaxanthin – protect the eye’s macula, which is responsible for central and detailed vision.

23 Nov 2018

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

22 Nov 2018

Antidepressant use increased after Brexit vote

A new study has shown that use of antidepressants have risen in England after the United Kingdom voted to leave the European Union. There has also been a sharp fall in prescription of other medications, the study notes.

22 Nov 2018

Mannose - nutritional supplement, could slow some cancers

Mannose is a sugary nutritional supplement that has shown promise in slowing down the growth of certain cancers in laboratory mice. The results of the five year-long study from Glasgow were published in the latest issue of the journal Nature.

21 Nov 2018

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Mannose sugar, a nutritional supplement, can both slow tumor growth and enhance the effects of chemotherapy in mice with multiple types of cancer.

21 Nov 2018

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Mannose, a type of sugar, has been shown to slow tumor growth and enhance chemotherapy in mouse models of certain cancers.

21 Nov 2018

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

20 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

Infant gut microbes altered by mother's obesity may increase risk for future disease

Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers at the University of Colorado Anschutz Medical Campus.

16 Nov 2018

Supplements News and Research

Researchers confirm link between neonatal vitamin D deficiency and schizophrenia

Elevated hormone flags liver disease in mice with serious genomic disorder

Newborns with vitamin D deficiency have increased risk of schizophrenia later in life

Fish oil does not increase perioperative bleeding in surgery patients

FDA approves new drug for treatment of rare autoimmune disorder

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

Johns Hopkins researchers report challenges in treating severe crisis pain of sickle cell disease

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

Certain dietary supplements can have beneficial effect on sperm quality, study suggests

NanoSphere develops new intraoral product that has potential to revolutionize cannabis therapies

Supplements of key nutrients can help people to see better

FDA approves new treatment for AML patients

Antidepressant use increased after Brexit vote

Mannose - nutritional supplement, could slow some cancers

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

FDA approves antibacterial drug to treat travelers' diarrhea

New first-line treatment for peripheral T-cell lymphoma approved by FDA

Infant gut microbes altered by mother's obesity may increase risk for future disease

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News